Terms: = Prostate cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
287 results:
1. Incidental findings on staging rectal MRI: clinical significance and outcomes.
Tang YZ; Alabousi A
Acta Radiol; 2024 Apr; 65(4):374-382. PubMed ID: 38115675
[TBL] [Abstract] [Full Text] [Related]
2. Rational use of Ga-68 PSMA PET-CT according to nomograms and risk groups for the detection of lymph node metastasis in prostate cancer.
Madendere S; Kılıç M; Köseoğlu E; Aykanat İC; Eden AB; Coşkun B; Tekkalan FB; Balbay MD
Urol Oncol; 2024 Feb; 42(2):29.e9-29.e15. PubMed ID: 38114351
[TBL] [Abstract] [Full Text] [Related]
3. Synthesis, molecular docking and biological evaluation of 1,2,4-oxadiazole based novel non-steroidal derivatives against prostate cancer.
Kumar S; Wadhwa P
Bioorg Chem; 2024 Feb; 143():107029. PubMed ID: 38091717
[TBL] [Abstract] [Full Text] [Related]
4. Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
Baylan B; Ulusoy K; Ekenci B; Kartal IG
Asian J Surg; 2024 Mar; 47(3):1360-1365. PubMed ID: 38065745
[TBL] [Abstract] [Full Text] [Related]
5. Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across cancer Types.
Kasi PM; Lee JK; Pasquina LW; Decker B; Vanden Borre P; Pavlick DC; Allen JM; Parachoniak C; Quintanilha JCF; Graf RP; Schrock AB; Oxnard GR; Lovly CM; Tukachinsky H; Subbiah V
Clin Cancer Res; 2024 Feb; 30(4):836-848. PubMed ID: 38060240
[TBL] [Abstract] [Full Text] [Related]
6. A brief mind-body intervention to reduce pain and anxiety during prostate needle biopsy: a clinically integrated randomized controlled trial with 2-staged consent.
Gaffney CD; Vertosick EA; Carlsson SV; Lin X; Wolchasty N; Hardbattle R; Vickers AJ; Ehdaie B
Urol Oncol; 2023 Dec; 41(12):484.e1-484.e5. PubMed ID: 37977915
[TBL] [Abstract] [Full Text] [Related]
7. cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
[TBL] [Abstract] [Full Text] [Related]
8. [Levels of tPSA and fPSA and count of peripheral blood neutrophils in the diagnosis of prostate cancer].
Zhang SQ; Su Q
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1089-1095. PubMed ID: 37846628
[TBL] [Abstract] [Full Text] [Related]
9. LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients.
Boehle A; Zywietz D; Robrahn-Nitschke I; Lusch A; König IR
Urol Oncol; 2023 Nov; 41(11):454.e17-454.e24. PubMed ID: 37714724
[TBL] [Abstract] [Full Text] [Related]
10. Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study.
Mingdong W; Xiang G; Yongjun Q; Mingshuai W; Hao P
BMC Cancer; 2023 Sep; 23(1):854. PubMed ID: 37697271
[TBL] [Abstract] [Full Text] [Related]
11. Targeted Therapy for cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Choi HY; Chang JE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686423
[TBL] [Abstract] [Full Text] [Related]
12. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
[TBL] [Abstract] [Full Text] [Related]
13. Reevaluation of bromodomain ligands targeting BAZ2A.
Cazzanelli G; Vedove AD; Parolin E; D'Agostino VG; Unzue A; Nevado C; Caflisch A; Lolli G
Protein Sci; 2023 Sep; 32(9):e4752. PubMed ID: 37574751
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes.
Servetto A; Di Maio M; Salomone F; Napolitano F; Paratore C; Di Costanzo F; Viscardi G; Santaniello A; Formisano L; Bianco R
BMC Med; 2023 Jul; 21(1):234. PubMed ID: 37400832
[TBL] [Abstract] [Full Text] [Related]
15. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
[TBL] [Abstract] [Full Text] [Related]
16. Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.
Wang Z; Li Y; Zhao W; Jiang S; Huang Y; Hou J; Zhang X; Zhai Z; Yang C; Wang J; Zhu J; Pan J; Jiang W; Li Z; Ye M; Tan M; Jiang H; Dang Y
Signal Transduct Target Ther; 2023 May; 8(1):175. PubMed ID: 37121942
[TBL] [Abstract] [Full Text] [Related]
17. Non-exercise estimated cardiorespiratory fitness and cancer incidence: The NIH-AARP diet and health study.
Vainshelboim B; Myers J; Matthews CE
J Sport Health Sci; 2023 Nov; 12(6):739-746. PubMed ID: 36828228
[TBL] [Abstract] [Full Text] [Related]
18. Projection of cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older.
Hong Y; Lee S; Moon S; Sung S; Lim W; Kim K; An S; Choi J; Ko KP; Kim I; Lee JE; Park SK
J Prev Med Public Health; 2022 Nov; 55(6):529-538. PubMed ID: 36475318
[TBL] [Abstract] [Full Text] [Related]
19. Longitudinal monitoring of cell-free DNA methylation in alk-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Patel RA; Coleman I; Roudier MP; Konnick EQ; Hanratty B; Dumpit R; Lucas JM; Ang LS; Low JY; Tretiakova MS; Ha G; Lee JK; True LD; De Marzo AM; Nelson PS; Morrissey C; Pritchard CC; Haffner MC
Cancer Res Commun; 2022 May; 2(5):277-285. PubMed ID: 36337169
[TBL] [Abstract] [Full Text] [Related]
[Next]